http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017214575-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94f3b8412f6df2247cdf3667fb19458f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3f932fdce624969815902d477b3106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1850e6c1091c1cc20a5c90b30b392627
publicationDate 2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017214575-A1
titleOfInvention Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy
abstract Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or Retinoid X Receptor active agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786555-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10213401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019197583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020128478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3709990-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10517843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3651764-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3651757-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532073-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874627-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940127-B2
priorityDate 2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008300312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016067336-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001018456-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6653322-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015092420-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID354203587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID354139477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229330853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132217713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID238545500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430628874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID238743423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89984002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID344166244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10314719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID238743416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9806356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231982918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226538493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132157675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226816622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10835443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID240435603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID676159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132217726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11755040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147418554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44566108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466115312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5289501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230146509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID354203601

Total number of triples: 93.